ANALYSIS OF N-RAS GENE-MUTATIONS IN MEDULLOBLASTOMAS BY POLYMERASE CHAIN-REACTION AND OLIGONUCLEOTIDE PROBES IN FORMALIN-FIXED, PARAFFIN-EMBEDDED TISSUES

被引:9
作者
IOLASCON, A
LANIA, A
BADIALI, M
PESSION, A
SAGLIO, G
GIANGASPERO, F
DELGIUDICE, EM
PERROTTA, S
CUTILLO, S
机构
[1] UNIV BOLOGNA,DEPT EXPTL PATHOL,I-40126 BOLOGNA,ITALY
[2] UNIV BOLOGNA,PEDIAT CLIN,I-40126 BOLOGNA,ITALY
[3] UNIV TURIN,DEPT BIOMED SCI,I-10124 TURIN,ITALY
[4] CNR,INT INST BGENET & BIOPHYS,NAPLES,ITALY
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 1991年 / 19卷 / 04期
关键词
ONCOGENES; AMPLIFICATION; N-RAS; MEDULLOBLASTOMA;
D O I
10.1002/mpo.2950190406
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Precise data on the incidence of transforming ras oncogenes in pediatric tumors and the correlations with the histopathological properties of the tumors are very limited. Additionally the presence of ras activation in medulloblastomas has not been investigated so far. Using a combination of techniques including in vitro gene amplification by polymerase chain reaction (PCR) and detection of single base mutations by sequence-specific oligonucleotides we studied N-ras activation (mutations at codon 12, 13, and 61) in 32 medulloblastomas. DNA was isolated from 20-mu-m sections of formalin-fixed paraffin-embedded tissue. Mutations were found in 3 out of 32 examined medulloblastomas. In all cases only mutations of codon 61 were found: two of three mutations were C to A mutations at position 1 of the codon 61 (leading to a substitution of a glutamine residue for a lysine) and one was A to T mutation at position 3 in the same codon (glutamine-histidine). Our results indicate 10% incidence N-ras mutation in medulloblastoma, higher than in other CNS tumors studied so far. The main advantages of the procedure described are its greatly improved sensitivity, the increased speed with which tumor samples can be analyzed, and the possibility of using paraffin-embedded sections to analyze various rare tumors in retrospect.
引用
收藏
页码:240 / 245
页数:6
相关论文
共 27 条
  • [1] MOST HUMAN CARCINOMAS OF THE EXOCRINE PANCREAS CONTAIN MUTANT C-K-RAS GENES
    ALMOGUERA, C
    SHIBATA, D
    FORRESTER, K
    MARTIN, J
    ARNHEIM, N
    PERUCHO, M
    [J]. CELL, 1988, 53 (04) : 549 - 554
  • [2] INCIDENCE OF RAS GENE-MUTATIONS IN NEURO-BLASTOMA
    BALLAS, K
    LYONS, J
    JANSSEN, JWG
    BARTRAM, CR
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1988, 147 (03) : 313 - 314
  • [3] RAS GENES
    BARBACID, M
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 : 779 - 827
  • [4] MICROINJECTION OF THE RAS ONCOGENE PROTEIN INTO PC12 CELLS INDUCES MORPHOLOGICAL-DIFFERENTIATION
    BARSAGI, D
    FERAMISCO, JR
    [J]. CELL, 1985, 42 (03) : 841 - 848
  • [5] BOS JL, 1987, BLOOD, V69, P1237
  • [6] PREVALENCE OF RAS GENE-MUTATIONS IN HUMAN COLORECTAL CANCERS
    BOS, JL
    FEARON, ER
    HAMILTON, SR
    VERLAANDEVRIES, M
    VANBOOM, JH
    VANDEREB, AJ
    VOGELSTEIN, B
    [J]. NATURE, 1987, 327 (6120) : 293 - 297
  • [7] GENETIC MECHANISMS IN TUMOR INITIATION AND PROGRESSION .10. THE RAS GENE FAMILY AND HUMAN CARCINOGENESIS
    BOS, JL
    [J]. MUTATION RESEARCH, 1988, 195 (03): : 255 - 271
  • [8] BOS JL, 1989, CANCER RES, V49, P4682
  • [9] COTTON RGH, 1989, BIOCHEM J, V263, P1
  • [10] TRANSFORMING GENES OF HUMAN HEMATOPOIETIC TUMORS - FREQUENT DETECTION OF RAS-RELATED ONCOGENES WHOSE ACTIVATION APPEARS TO BE INDEPENDENT OF TUMOR PHENOTYPE
    EVA, A
    TRONICK, SR
    GOL, RA
    PIERCE, JH
    AARONSON, SA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (16): : 4926 - 4930